Traxler; Peter

Patent Applications and Registrations

Patent applications and USPTO patent grants for Traxler; Peter.The latest application filed is for "pyrrolopyrimidine derivatives for treating proliferative diseases".

Company Profile

0.16.12

Traxler; Peter - Schonenbuch CH
Traxler; Peter - Schoenenbuch CH
Traxler, Peter - Sch?ouml;nenbuch CH
Traxler; Peter - Allschwil CH

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Use of imatinib (glivec,sti-571) to inhibit breast cancer resistance protein (BCRP)-mediated resistance to therapeutic agents Grant 7,879,868 - Houghton , et al. February 1, 2	2011-02-01
Combination comprising a signal transduction inhibitor and an epothilone derivative Grant 7,723,339 - Brandt , et al. May 25, 2	2010-05-25
Pyrrolopyrimidine Derivatives For Treating Proliferative Diseases App 20090247548 - Caravatti; Giorgio ; et al.	2009-10-01
4-amino-6-phenyl-pyrrolo[2,3-d]pyrimidine derivatives Grant 7,390,805 - Bold , et al. June 24, 2	2008-06-24
7H-pyrrolo[2,3-d]pyrimidine derivatives Grant 7,323,469 - Bold , et al. January 29, 2	2008-01-29
4-amino-6-phenyl-pyrrolo[2,3-d]pyrimidine derivatives Grant 7,244,729 - Bold , et al. July 17, 2	2007-07-17
4-amino-6-phenyl-pyrrolo[2,3-d]pyrimidine Derivatives App 20070161632 - Bold; Guido ; et al.	2007-07-12
Protein kinase inhibitors App 20070149535 - Berset; Catherine ; et al.	2007-06-28
Combination comprising an agent decreasing VEGF activity and an agent decreasing EGF activity App 20060270665 - Wood; Jeanette Marjorie ; et al.	2006-11-30
Use of imatinib (glivec,sti-571) to inhibit breast cancer resistance protein (bcrp)-mediated resistance to therapeutic agents App 20060135527 - Houghton; PeterJ ; et al.	2006-06-22
7H-pyrrolo[2,3-d]pyrimidine derivatives App 20040248911 - Bold, Guido ; et al.	2004-12-09
4-amino-6-phenyl-pyrrolo[2,3-d]pyrimidine derivatives App 20040242600 - Bold, Guido ; et al.	2004-12-02
Combination comprising a signal transduction inhibitor and an epothilone derivative App 20040132754 - Brandt, Ralf ; et al.	2004-07-08
Phthalazines with angiogenesis inhibiting activity Grant 6,710,047 - Bold , et al. March 23, 2	2004-03-23
Combination comprising an agent decreasing vegf activity and an agent decreasing egf activity App 20040034026 - Wood, Jeannette M ; et al.	2004-02-19
Phthalazines with angiogenesis inhibiting activity App 20030191129 - Bold, Guido ; et al.	2003-10-09
Use of organic compounds App 20030139430 - Resta, Debra Jane ; et al.	2003-07-24
Phthalazines with angiogenesis inhibiting activity App 20020091261 - Bold, Guido ; et al.	2002-07-11
Phthalazines with angiogenesis inhibiting activity Grant 6,258,812 - Bold , et al.	2001-07-10
Pyrimidine derivatives and processes for the preparation thereof Grant 6,251,911 - Bold , et al. June 26, 2	2001-06-26
Substituted pyrrolopyrimidines and processes for their preparation Grant 6,180,636 - Traxler , et al. January 30, 2	2001-01-30
Pyrrolopyrimidines and processes for their preparation Grant 6,140,317 - Traxler , et al. October 31, 2	2000-10-31
Pyrrolopyrimidines and processes for the preparation thereof Grant 6,140,332 - Traxler , et al. Oc	2000-10-31
Pyrrolopyrimidine derivatives having pharmacological activity Grant 6,096,749 - Traxler , et al. August 1, 2	2000-08-01
Pyrazole derivatives and processes for the preparation thereof Grant 5,981,533 - Traxler , et al. November 9, 1	1999-11-09
Pyrrolopyrimidine derivatives having pharmacological activity Grant 5,686,457 - Traxler , et al. November 11, 1	1997-11-11
Rifamycin hydrazones, pharmaceutical compositions containing them and their use Grant 4,551,450 - Traxler November 5, 1	1985-11-05
Papulacandin derivatives and pharmaceutical compositions containing same Grant 4,278,665 - Traxler , et al. July 14, 1	1981-07-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.